PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs ZBH |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 0.33 | 20.9 | 63.3% | -49% |
| UHS | Universal Health Services, Inc. | 0.40 | 6.5 | 16.2% | -38% |
| IQV | IQVIA Holdings Inc. | 0.74 | 29.9 | 40.2% | +15% |
| SYK | Stryker Corporation | 2.32 | 34.4 | 14.8% | +258% |
| STE | STERIS plc | 2.50 | 28.1 | 11.2% | +286% |